Ignite Creation Date:
2025-12-24 @ 4:23 PM
Ignite Modification Date:
2025-12-25 @ 8:40 PM
Study NCT ID:
NCT00358566
Status:
TERMINATED
Last Update Posted:
2008-05-19
First Post:
2006-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Sponsor:
Pharmexa A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2008-08
Completion Date Type:
ESTIMATED
First Submit Date:
2006-07-14
First Submit QC Date:
None
Study First Post Date:
2006-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-05-16
Last Update Post Date:
2008-05-19
Last Update Post Date Type:
ESTIMATED